Global Antimicrobial Resistance and Use Surveillance System on the African continent: Early implementation 2017-2019.

Autor: Tornimbene B; AMR Division, Surveillance, Prevention and Control Department, World Health Organization, Geneva, Switzerland., Eremin S; AMR Division, Surveillance, Prevention and Control Department, World Health Organization, Geneva, Switzerland., Abednego R; National Health Laboratory Quality Assurance and Training Centre (NHLQATC), Tanzania, Dar es Salaam, United Republic of Tanzania., Abualas EO; National Public Health Laboratory, Federal Ministry of Health, Khartoum, Sudan., Boutiba I; Faculty of Medicine, University of Tunis El Manar, Tunis, Tunisia., Egwuenu A; Nigeria Center for Disease Control, Abuja, Nigeria., Fuller W; Antimicrobial Resistance (AMR) World Health Organization, Regional Office for Africa, Brazzaville, Congo., Gahimbare L; Antimicrobial Resistance (AMR) World Health Organization, Regional Office for Africa, Brazzaville, Congo., Githii S; National Microbiology Reference Lab, National Public Health Laboratories, Nairobi, Kenya., Kasambara W; Ministry of Health, Lilongwe, Malawi., Lukwesa-Musyani C; Lusaka District Laboratory, University of Zambia, Lusaka, Zambia., Miamina FA; Department of Health Watch, Epidemiological Surveillance and Response (DVSSER), Antananarivo, Madagascar., Mtapuri-Zinyowera S; National Microbiology Reference Laboratory, Zimbabwe, Harare, Zimbabwe., Najjuka G; Department of Microbiology, Joint Clinical Research Centre (JCRC), Kampala, Uganda., Perovic O; Centre for Healthcare-Associated Infections, Antimicrobial Resistance and Mycoses (CHARM), Johannesburg, South Africa., Zayed B; World Health Organization, Regional Office for East Mediterranean, Cairo, Egypt., Ahmed YA; World Health Organization, Regional Office for Africa, Brazzaville, Congo., Ismail MT; World Health Organization, Regional Office for East Mediterranean, Cairo, Egypt., Pessoa da Silva CL; AMR Division, Surveillance, Prevention and Control Department, World Health Organization, Geneva, Switzerland.
Jazyk: angličtina
Zdroj: African journal of laboratory medicine [Afr J Lab Med] 2022 Aug 31; Vol. 11 (1), pp. 1594. Date of Electronic Publication: 2022 Aug 31 (Print Publication: 2022).
DOI: 10.4102/ajlm.v11i1.1594
Abstrakt: Background: Antimicrobial resistance (AMR) is becoming a critical public health issue globally. The World Health Organization launched the Global Antimicrobial Resistance and Use Surveillance System (GLASS) to support the strengthening of the AMR evidence base.
Objective: The article describes the evolution of national AMR surveillance systems and AMR data reporting of countries in the African continent between 2017 and 2019, and the constraints, perceived impact and value of the participation in GLASS.
Methods: Data on implementation of national surveillance systems and AMR rates were submitted to GLASS between 2017 and 2019 and summarised though descriptive statistics. The information on constraints and perceived impact and value in GLASS participation was collected though a set of questionnaires.
Results: Between 2017 and 2019, Egypt, Ethiopia, Madagascar, Malawi, Mali, Mozambique, Nigeria, South Africa, Sudan, Tunisia, Uganda and Zambia submitted data to GLASS. The main constraints listed are linked to scarce laboratory capacity and capability, limited staffing, budget issues, and data management. Moreover, while the data are not yet nationally representative, high resistance rates were reported to commonly-used antibiotics, as the emerging resistance to last treatment options.
Conclusion: Despite the limitations, more and more countries in the African continent are working towards reaching a status that will enable them to report AMR data in a complete and systematic manner. Future improvements involve the expansion of routine surveillance capacity for several countries and the implementation of surveys that allow to effectively define the magnitude of AMR in the continent.
Competing Interests: The authors declare that they have no financial or personal relationships that may have inappropriately influenced them in writing this article.
(© 2022. The Authors.)
Databáze: MEDLINE
Nepřihlášeným uživatelům se plný text nezobrazuje